| Not Yet Recruiting | The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Health Healthy, Fasting, Fed | Phase 1 | 2026-07-01 |
| Active Not Recruiting | A Clinical Study in Healthy Adults to See How the Body Processes and How Safe a Tablet That Combines Gemiglipt Healthy Volunteers, Fasting Conditions | Phase 1 | 2026-01-09 |
| Completed | A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, Fed Conditions, Healthy Volunteer | Phase 1 | 2025-09-29 |
| Recruiting | A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Diphtheria, Tetanus, Pertussis | Phase 2 / Phase 3 | 2025-05-30 |
| Recruiting | Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovaria Female Infertility | Phase 4 | 2025-02-15 |
| Completed | A Study to Compare Eutropin Formulations in Healthy Volunteers for Bioavailability, Safety, and Tolerability Healthy Volunteers | Phase 1 | 2025-01-13 |
| Not Yet Recruiting | Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healt Diphtheria, Tetanus, Pertussis | Phase 2 | 2024-10-02 |
| Recruiting | Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezo Non-small Cell Lung Cancer(NSCLC), Head and Neck Squamous Cell Carcinoma(HNSCC), Renal Cell Carcinoma(RCC) | Phase 1 | 2024-06-05 |
| Unknown | A Phase 2 Study to Assess Efficacy and Safety of LB54640 in Patients With Genetic Obesity POMC Deficiency Obesity, PCSK1 Deficiency Obesity, LEPR Deficiency Obesity | Phase 2 | 2023-12-01 |
| Completed | Effect of Tigulixostat on the Pharmacokinetics of Theophylline Gout, Hyperuricemia | Phase 1 | 2023-10-31 |
| Completed | Observational Study of Triple Combination Therapy of Zemidapa Tab. and Metformin in Type 2 Diabetes Mellitus P Type 2 Diabetes Mellitus | — | 2023-10-26 |
| Unknown | A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults Diphtheria, Tetanus, Pertussis | Phase 1 | 2023-07-17 |
| Unknown | Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Prima Diphtheria, Tetanus, Pertussis | Phase 2 / Phase 3 | 2023-04-01 |
| Completed | Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients Gout, Hyperuricemia, Gout Flare | Phase 3 | 2023-03-30 |
| Completed | Study to Evaluate Eupolio(IPV)'s Safety, Long-term Protective Effect and Boosting Effect of One Booster Dose i Poliomyelitis, Vaccine Reaction | Phase 3 | 2023-01-10 |
| Completed | Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients Gout, Hyperuricemia, Gout Flare | Phase 3 | 2022-10-25 |
| Completed | A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of LG00034053 in Patients With Knee OA Osteoarthritis, Knee | Phase 1 / Phase 2 | 2022-04-27 |
| Completed | A Study of LC542019 in Healthy Subjects and Subjects With T2DM Healthy, Diabetes Mellitus, Type 2 | Phase 1 | 2022-03-25 |
| Completed | Clinical Investigation of YVOIRE Y-Solution 360 for Lip Augmentation in China Lip Augmentation | N/A | 2022-01-11 |
| Unknown | Food-effect Bioavailability of Gemigliptin and Dapagliflozin 50/10 mg Healthy Volunteers | Phase 1 | 2022-01-01 |
| Completed | A Randomized, Multicenter, Evaluator-Blinded, Active-Controlled, Parallel-Group Investigation to Evaluate the Correction of Nasolabial Folds | Phase 4 | 2021-10-21 |
| Completed | Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Femal Hyperuricemia, Gout, Qt Interval, Variation in | EARLY_Phase 1 | 2021-09-23 |
| Completed | Retrospective Cohort Observational Study to Evaluate the Effectiveness and Safety of Fresh or Frozen Embryo Tr Infertility, Female | — | 2021-09-14 |
| Completed | Relative Bioavailability Study to Assess an LC350189 Tablet Compared to an LC350189 Capsule in Healthy Adults Gout, Hyperuricemia | Phase 1 | 2021-07-31 |
| Completed | Effectiveness and Safety of YVOIRE Y-Solution 540 Wrinkles in the Nasolabial Folds | N/A | 2021-07-01 |
| Completed | Clinical Study to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected for Jawline Contouri Jaw Volume Deficit | N/A | 2021-06-25 |
| Unknown | Observational Study Gemigliptin in Patients Aged ≥ 65 Years With Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus | — | 2021-06-24 |
| Completed | To Evaluate the Performance and Safety of YVOIRE Volume Plus for Improvement of Mid-face Volume Midface Volume Deficit | N/A | 2021-03-22 |
| Unknown | A Phase I Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetic Characteristics of TT-01 Healthy | Phase 1 | 2021-02-17 |
| Completed | To Assess the Safety and Effectiveness of Hyruan ONE Versus a Comparator for the Treatment of Knee Osteoarthri Osteoarthritis (OA) of the Knee | N/A | 2021-02-03 |
| Completed | To Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected Into the Mid-Face Volume Defects in the Mid-face | N/A | 2020-11-25 |
| Unknown | Clinical Trial to Compare the PK of the Fixed-dose Combinations and Each Component of Gemigliptin/Dapagliflozi T2DM | Phase 1 | 2020-10-01 |
| Unknown | To Evaluate Safety and Effectiveness of RovatitanTab. Hypertension, Hyperlipidemias | — | 2020-09-01 |
| Completed | Bioequivalence Study for Fixed Dose Combination Zemimet® SR Tab. 50/1000 and Coadministration of Gemigliptin 5 Type 2 Diabetes | Phase 1 | 2020-08-19 |
| Completed | Compare the Pharmacokinetics, Pharmacodynamics and Safety/Tolerability of LC51-0255 Film-coated Tablet (SG85) Ulcerative Colitis | Phase 1 | 2020-07-01 |
| Unknown | A Study to Evaluate the Efficacy and Safety of Dual add-on Therapy With Gemigliptin 50 mg and Dapagliflozin 10 Diabetes Mellitus, Type 2 | Phase 3 | 2020-06-30 |
| Completed | A Multicenter, Prospective Observational Study to Evaluate the Incidence of Delayed-onset Nodules of YVOIRE Y- Healthy Condition | — | 2020-06-18 |
| Terminated | To Evaluate the Performance and Safety of YVOIRE Y Solution 360 Versus Comparator for Lips and Perioral Area. Lip Augmentation | N/A | 2020-06-05 |
| Withdrawn | Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis Ulcerative Colitis | Phase 2 | 2020-04-01 |
| Completed | A First in Human Study to Assess the Safety, Tolerability of LB54640 in in Healthy Overweight and Obese Subjec Obese, Overweight, Healthy | Phase 1 | 2020-03-16 |
| Completed | Mass Balance Study of [14C]LC350189 in Healthy Volunteers Gout, Hyperuricemia | Phase 1 | 2020-02-26 |
| Completed | The Effect of Naproxen on the Pharmacokinetic Profile of LC350189 in Healthy Adults Gout, Hyperuricemia | Phase 1 | 2020-01-22 |
| Completed | A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia Gout, Hyperuricemia | Phase 2 | 2019-12-02 |
| Completed | Renal PK Study of LC350189 Gout, Hyperuricemia | Phase 1 | 2019-11-19 |
| Completed | The Effect of Colchicine on the Pharmacokinetic Profile of LC350189 in Healthy Aldults. Gout, Hyperuricemia | Phase 1 | 2019-11-05 |
| Unknown | Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants Diphtheria, Tetanus, Pertussis | Phase 2 | 2019-11-01 |
| Unknown | Food-effect Bioavailability of Fixed Dose Combination Zemimet® SR Tab. 50/1000 mg Under Fed and Fasting Condit Type2 Diabetes | Phase 1 | 2019-11-01 |
| Unknown | Bioequivalence Study for Gemigliptin/Metformin 50/1000 mg and Coadministration of Gemigliptin 50 mg and Metfor Type2 Diabetes | Phase 1 | 2019-11-01 |
| Terminated | A Study of YVOIRE Y-Solution 360 for Hand Augmentation to Correct Volume Loss Dorsal Hand Volume Loss | N/A | 2019-09-27 |
| Unknown | A Phase IV Study to Assess the Safety of EupentaTM Inj Hepatitis B, Diphtheria, Haemophilus Influenzae Type B Infection | Phase 4 | 2019-09-23 |
| Completed | 6x3 Crossover, Bioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy Volun Bioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy Volunteers | Phase 1 | 2019-09-10 |
| Completed | An Ascending Dose, Single/Multiple Dosing, Food Effect Clinical Trial to Evaluate Pharmacokinetics, Safety and Type 2 Diabetes Mellitus | Phase 1 | 2019-07-02 |
| Completed | A Study to Evaluate the Efficacy and Safety of Gemigliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Con Diabetes Mellitus, Type 2 | Phase 3 | 2019-05-13 |
| Unknown | BE Study of Bilayer Combination of Gemigliptin/Rosuvastatin 50/20mg in Comparison to Monolayer Combination. Diabetes Mellitus, Type 2, Dyslipidemias | Phase 1 | 2019-03-21 |
| Completed | Observational Study to Develop Dosing Chart Infertile Women Undergoing IVF or ICSI | — | 2018-08-03 |
| Unknown | A Study to Evaluate the Safety and Immunogeneicity of Multivalent Pneumococcal Conjugate Vaccine in Healthy Ad Pneumococcal Infection | Phase 1 | 2018-07-01 |
| Completed | Evaluating a Pharmacokinetic Drug Interaction Between LGEV1801 and LGEV1802 Healthy Male Volunteers | Phase 1 | 2018-05-28 |
| Completed | A Study to Evaluate the Safety and Immunogenecity of LBVE(Multivalent Pneumococcal Conjugate Vaccine) in Healt Pneumococcal Infection | Phase 2 | 2018-05-25 |
| Unknown | Gemigliptin, Dapagliflozin, Empagliflozin DDI Study Type 2 Diabetes Mellitus | Phase 1 | 2018-04-05 |
| Completed | Observational Study of Synovian® Inj. in Patients With Osteoarthritis in the Knee Osteoarthritis in the Knee | — | 2018-03-09 |
| Completed | BE Study of the Combinations of Gemigliptin/Metformin HCl Extended Release 50/1000mg(25/500mg x 2 Tablets) in Healthy Male Volunteers | Phase 1 | 2017-12-13 |
| Completed | Trial to Evaluate the Efficacy on Glycemic Variability and Safety of Gemigliptin Compared With Dapagliflozin A Type 2 Diabetes Mellitus | Phase 4 | 2017-08-09 |
| Completed | A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults Diphtheria, Tetanus, Pertussis | Phase 1 | 2017-07-03 |
| Completed | A Phase I Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetic Characteristics of LC28-0 Healthy | Phase 1 | 2017-06-07 |
| Unknown | Relative Bioavailability Among Different Eutropin Formulations Relative Bioavailability | Phase 1 | 2017-05-31 |
| Completed | A Study To Evaluate The Safety, Pharmacokinetics/Pharmacodynamics (PK/PD) and Food Effect Of LC51-0255 Healthy | Phase 1 | 2017-05-31 |
| Completed | A Clinical Study to Evaluate the Safety and Immunogenicity of Inactivated Poliomyelitis Vaccine in Healthy Inf Poliomyelitis | Phase 2 / Phase 3 | 2017-05-31 |
| Recruiting | Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children Growth Hormone Deficiency, Turner Syndrome, Chronic Renal Failure | — | 2012-01-01 |